IPO registrations (S-1, F-1) · Registrants
Benitec Biopharma LTD/ADR
- SEC CIK
- 1552795 · filings on EDGAR ↗
- Registration
- Form F-1, first filed 2015-06-22, last 2019-12-09; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2015-08-18; declared effective 2015-08-17
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Business address
- LEVEL 14, 114 WILLIAM ST, Melbourne Vic, C3 3000
- EDGAR entity type
- other
Offering terms
- Shares offered
- 1,500,000
- Listing
- Nasdaq under the symbol BNTC
- Lead underwriters
- Maxim Group
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
Filings 14
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-06-22 | F-1 | F-1 (foreign registration) | Benitec Biopharma LTD/ADR | 0001193125-15-230004 ↗ |
| 2015-07-27 | F-1/A | F-1/A (amendment) | Benitec Biopharma LTD/ADR | 0001193125-15-263482 ↗ |
| 2015-08-10 | F-1/A | F-1/A (amendment) | Benitec Biopharma LTD/ADR | 0001193125-15-284501 ↗ |
| 2015-08-13 | F-1/A | F-1/A (amendment) | Benitec Biopharma LTD/ADR | 0001193125-15-289189 ↗ |
| 2015-08-17 | EFFECT | EFFECT (declared effective) | Benitec Biopharma LTD/ADR | 9999999995-15-002307 ↗ |
| 2015-08-18 | 424B4 | 424B4 (final prospectus) | Benitec Biopharma LTD/ADR | 0001193125-15-294057 ↗ |
| 2016-04-19 | EFFECT | EFFECT (declared effective) | Benitec Biopharma LTD/ADR | 9999999995-16-004263 ↗ |
| 2016-11-18 | EFFECT | EFFECT (declared effective) | Benitec Biopharma LTD/ADR | 9999999995-16-006264 ↗ |
| 2017-07-05 | EFFECT | EFFECT (declared effective) | Benitec Biopharma LTD/ADR | 9999999995-17-001739 ↗ |
| 2017-12-11 | EFFECT | EFFECT (declared effective) | Benitec Biopharma LTD/ADR | 9999999995-17-003192 ↗ |
| 2019-12-09 | F-1 | F-1 (foreign registration) | Benitec Biopharma LTD/ADR | 0001193125-19-308668 ↗ |
| 2019-12-16 | EFFECT | EFFECT (declared effective) | Benitec Biopharma LTD/ADR | 9999999995-19-002830 ↗ |
| 2020-04-16 | EFFECT | EFFECT (declared effective) | Benitec Biopharma LTD/ADR | 9999999995-20-000763 ↗ |
| 2020-04-16 | EFFECT | EFFECT (declared effective) | Benitec Biopharma LTD/ADR | 9999999995-20-000765 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-08-13 | F-1/A | registration statement | 1,500,000 | - | Nasdaq BNTC | 1 | primary document; shares headline, cover names 1 | document ↗ | ||
| 2015-08-18 | 424B4 | final prospectus | 1,500,000 | - | Nasdaq BNTC | 1 | primary document; shares headline, cover names 1 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Others with the same interests
SIC industry Pharmaceutical Preparations, C3 first:
- Pharmaxis Ltd. C3
- Propanc Biopharma, Inc. C3
- Parnell Pharmaceuticals Holdings Ltd C3
- Immuron Ltd C3
- Beroni Group Ltd C3
- Medlab Clinical Ltd. C3
- Telix Pharmaceuticals Ltd C3
- MorphoSys AG 2M
- Affimed N.V. 2M
- InflaRx N.V. 2M
In other datasets, the same topic (Health) in C3:
- Form D issuer: Botanix Pharmaceuticals Ltd. (Form D private offerings)
Interests: Pharmaceutical Preparations · Health